ECSP088682A - Modulación de la formación ósea - Google Patents
Modulación de la formación óseaInfo
- Publication number
- ECSP088682A ECSP088682A EC2008008682A ECSP088682A ECSP088682A EC SP088682 A ECSP088682 A EC SP088682A EC 2008008682 A EC2008008682 A EC 2008008682A EC SP088682 A ECSP088682 A EC SP088682A EC SP088682 A ECSP088682 A EC SP088682A
- Authority
- EC
- Ecuador
- Prior art keywords
- ror2
- bone
- relates
- bone formulation
- modulation
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 208000010392 Bone Fractures Diseases 0.000 abstract 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000006471 dimerization reaction Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- 230000004952 protein activity Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/108—Osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77453406P | 2006-02-17 | 2006-02-17 | |
| US84423906P | 2006-09-13 | 2006-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088682A true ECSP088682A (es) | 2008-09-29 |
Family
ID=38437973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2008008682A ECSP088682A (es) | 2006-02-17 | 2008-08-15 | Modulación de la formación ósea |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090047287A1 (https=) |
| EP (1) | EP1984395A2 (https=) |
| JP (1) | JP2009527485A (https=) |
| KR (1) | KR20080095269A (https=) |
| AR (1) | AR060104A1 (https=) |
| AU (1) | AU2007217779A1 (https=) |
| BR (1) | BRPI0707864A2 (https=) |
| CA (1) | CA2638803A1 (https=) |
| CR (1) | CR10212A (https=) |
| EC (1) | ECSP088682A (https=) |
| IL (1) | IL193271A0 (https=) |
| MX (1) | MX2008010511A (https=) |
| NO (1) | NO20083497L (https=) |
| PA (1) | PA8715601A1 (https=) |
| PE (1) | PE20071309A1 (https=) |
| RU (1) | RU2008131052A (https=) |
| SV (1) | SV2009002997A (https=) |
| TW (1) | TW200800266A (https=) |
| WO (1) | WO2007098198A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2566886A1 (en) * | 2010-05-05 | 2013-03-13 | Addex Pharma SA | Methods and tools for screening agents exhibiting an activity on receptors of the tumor necrosis factor receptor superfamily |
| WO2013070033A1 (ko) * | 2011-11-09 | 2013-05-16 | 주식회사 아이엠헬스케어 | 골다공증 및 골회전율 진단 스트립 |
| KR101354826B1 (ko) * | 2011-12-08 | 2014-01-27 | 아주대학교산학협력단 | 중간엽줄기세포 렙틴분비능을 이용한 골다공증 예방 또는 치료용 물질 스크리닝 방법 |
| US20140322234A1 (en) * | 2012-01-03 | 2014-10-30 | The Board Of Trustees Of The Leland Stanford Junior University | Analysis and Targeting of ROR2 in Cancer |
| JP6463029B2 (ja) * | 2013-08-02 | 2019-01-30 | 有未 伊谷 | ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法 |
| ES2927112T3 (es) * | 2014-08-01 | 2022-11-02 | Purec Co Ltd | Método para evaluar la calidad de células madre mesenquimatosas humanas y un anticuerpo monoclonal para su uso en dicho método |
| JP7057557B2 (ja) * | 2015-07-31 | 2022-04-20 | 国立大学法人大阪大学 | 上皮疾患に対する治療及び／又は予防有効性を評価する方法、上皮疾患治療剤のスクリーニング方法、及び上皮疾患治療剤 |
| CN116751298A (zh) | 2016-05-13 | 2023-09-15 | 生物蛋白有限公司 | 抗ror2抗体、抗体片段和它们的免疫缀合物以及其用途 |
| GB201718985D0 (en) | 2017-11-16 | 2018-01-03 | Univ London Queen Mary | Treatment |
| US11793452B2 (en) | 2019-10-03 | 2023-10-24 | Johnson & Johnson Consumer Inc. | Method of visualizing and quantifying remineralization |
| CN115786252B (zh) * | 2023-02-07 | 2023-05-05 | 赛德特生物制药有限公司 | 人脐带间充质干细胞成骨诱导分化培养基及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312814A (en) * | 1992-12-09 | 1994-05-17 | Bristol-Myers Squibb Co. | α-phosphonocarboxylate squalene synthetase inhibitors |
| AU2001238571A1 (en) * | 2000-03-14 | 2001-09-24 | Regeneron Pharmaceuticals, Inc. | Methods of stimulating cartilage formation |
| EP1603586A1 (en) * | 2003-02-19 | 2005-12-14 | Aziz Ghahary | 14-3-3 protein for prevention and treatment of fibroproliferative disorders |
| AU2004233060A1 (en) * | 2003-04-16 | 2004-11-04 | Wyeth | A novel method of modulating bone-realted activity |
-
2007
- 2007-02-15 PE PE2007000174A patent/PE20071309A1/es not_active Application Discontinuation
- 2007-02-16 US US12/278,710 patent/US20090047287A1/en not_active Abandoned
- 2007-02-16 CA CA002638803A patent/CA2638803A1/en not_active Abandoned
- 2007-02-16 RU RU2008131052/13A patent/RU2008131052A/ru not_active Application Discontinuation
- 2007-02-16 EP EP07751280A patent/EP1984395A2/en not_active Withdrawn
- 2007-02-16 TW TW096106164A patent/TW200800266A/zh unknown
- 2007-02-16 MX MX2008010511A patent/MX2008010511A/es not_active Application Discontinuation
- 2007-02-16 BR BRPI0707864-1A patent/BRPI0707864A2/pt not_active IP Right Cessation
- 2007-02-16 AU AU2007217779A patent/AU2007217779A1/en not_active Abandoned
- 2007-02-16 PA PA20078715601A patent/PA8715601A1/es unknown
- 2007-02-16 AR ARP070100684A patent/AR060104A1/es not_active Application Discontinuation
- 2007-02-16 WO PCT/US2007/004510 patent/WO2007098198A2/en not_active Ceased
- 2007-02-16 JP JP2008555419A patent/JP2009527485A/ja not_active Withdrawn
- 2007-02-16 KR KR1020087021261A patent/KR20080095269A/ko not_active Withdrawn
-
2008
- 2008-08-05 IL IL193271A patent/IL193271A0/en unknown
- 2008-08-13 NO NO20083497A patent/NO20083497L/no not_active Application Discontinuation
- 2008-08-15 EC EC2008008682A patent/ECSP088682A/es unknown
- 2008-08-15 SV SV2008002997A patent/SV2009002997A/es unknown
- 2008-08-18 CR CR10212A patent/CR10212A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009527485A (ja) | 2009-07-30 |
| CR10212A (es) | 2008-10-03 |
| NO20083497L (no) | 2008-10-31 |
| BRPI0707864A2 (pt) | 2011-05-10 |
| RU2008131052A (ru) | 2010-03-27 |
| PA8715601A1 (es) | 2008-11-19 |
| US20090047287A1 (en) | 2009-02-19 |
| KR20080095269A (ko) | 2008-10-28 |
| MX2008010511A (es) | 2008-11-18 |
| AR060104A1 (es) | 2008-05-28 |
| TW200800266A (en) | 2008-01-01 |
| IL193271A0 (en) | 2011-08-01 |
| SV2009002997A (es) | 2009-04-17 |
| WO2007098198A3 (en) | 2008-03-13 |
| WO2007098198A2 (en) | 2007-08-30 |
| AU2007217779A1 (en) | 2007-08-30 |
| EP1984395A2 (en) | 2008-10-29 |
| CA2638803A1 (en) | 2007-08-30 |
| PE20071309A1 (es) | 2008-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088682A (es) | Modulación de la formación ósea | |
| CY1119127T1 (el) | Επιτοποι σκληροστινης | |
| CY1115588T1 (el) | Αναστολεις ανθρωπινης πρωτεϊνικης φωσφατασης τυροσινης-β και η φαρμακευτικη χρηση τους | |
| CY1114872T1 (el) | Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης | |
| CY1116377T1 (el) | Αναστολεις της ανθρωπινης πρωτεϊνικης φωσφατασης της τυροσινης και μεθοδοι χρησης | |
| BR0315275A (pt) | Anticorpos que se ligam a receptor de eritropoietina | |
| BR112012025568A2 (pt) | proteínas de ligação ao tnf-<244>. | |
| BRPI0411552A (pt) | anticorpos especìficos a esclerostina e métodos para aumentar a mineralização óssea | |
| CU23745A3 (es) | Anticuerpos para cd40 | |
| PH12019501319A1 (en) | Gremlin-1 crystal structure and inhibitory antibody | |
| TW200638934A (en) | Heteroaryl compounds as P2Y1 receptor inhibitors | |
| MX2009007688A (es) | Gel de fibrina para liberacion controlada de tgp-beta y usos del mismo. | |
| ATE403149T1 (de) | Diagnostische tests auf periostinbasis | |
| ATE423565T1 (de) | Verwendung von substanz p zur mobilisierung und proliferation mesenchymaler stammzellen und zur wundheilung | |
| DK1608399T3 (da) | Kompleks af sclerostin og noggin eller chordin og stoffer, som modulerer dannelsen af komplekset | |
| MX2019014448A (es) | Inmunoglobulinas de enlace a mmp13. | |
| NO20073369L (no) | Modulatorer av muskarinreseptorer | |
| GB0324656D0 (en) | A protein involved in ovarian cancer | |
| ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
| BRPI0406782A (pt) | Derivados de tieno-piridazinonas e seu uso na modulação de doenças autoimunes | |
| ATE417035T1 (de) | Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen | |
| HK40073521A (en) | Human antibodies to bone morphogenetic protein 6 | |
| BR0316995A (pt) | Modulação anti-sentido da expressão de mitoneet | |
| UY27815A1 (es) | Agonistas de prostaglandinas utiles en el tratamiento de desordenes oseos | |
| UA105783U (uk) | Спосіб прогнозування зрощення перелому |